Lobbyist Public Search

Records prior to registration year 2005 are not available online. Contact the Lobbyist Division here for assistance.	Search data is collected from registration records and disclosure reports submitted by lobbyists, lobbying entities, and their clients. Massachusetts General Law requires any party providing or retaining lobbying services to register annually, and submit disclosure reports twice a year.
	Your comments are welcome: submit feedback

Disclosure reporting details

Back to search detail summary

Lobbyist disclosure reporting period: 07/01/2024 - 12/31/2024

Lobbyist name	Mary Kaysen
Business name	BRISTOL-MYERS SQUIBB COMPANY
Address	118 Valley Street
City, state, zip code	Beverly Farms,, MA 01915
Country	US
Agent type	Both
Phone	978-232-1147

Operating Expenses

No operating expenses were filed for this disclosure reporting period.

Activities, Bill Numbers and Titles

Client: Bristol Myers Squibb Company

Total amount paid by client; lobbyist is unable to report compensation at activity level: $7,500.00

House / Senate	Bill Number or Agency Name	Bill title or activity	Agent position	Amount	Direct business association
House Bill	1074	An Act relative to cancer patient access to biomarker testing to provide appropriate therapy	Support	$0.00	n/a
House Bill	5100	An Act relative to strengthening Massachusetts’ economic leadership	Neutral	$0.00	n/a
House Bill	1215	An Act relative to pharmacy benefit managers	Support	$0.00	n/a
House Bill	1016	An Act to enact pharmacy benefit manager duties	Support	$0.00	n/a
House Bill	2869	An Act to insure fair taxation of affordable housing	Neutral	$0.00	n/a
House Bill	959	An Act prohibiting discrimination against 340b drug discount program participants	Oppose	$0.00	n/a
House Bill	3012	An Act authorizing project labor agreements	Neutral	$0.00	n/a
House Bill	934	An Act to enact the pharmacy benefit manager compensation reform	Support	$0.00	n/a
Senate Bill	2520	An Act relative to pharmaceutical access, costs and transparency	Oppose	$0.00	n/a
Senate Bill	704	An Act prohibiting discrimination against 340b drug discount program participants	Oppose	$0.00	n/a
House Bill	1205	An Act relative to prescription drug price transparency	Neutral	$0.00	n/a
House Bill	953	An Act relative to consumer deductibles	Support	$0.00	n/a
House Bill	4910	An Act promoting access and affordability of prescription drugs	Neutral	$0.00	n/a
House Bill	1201	An Act to promote transparency in prescription drug prices	Oppose	$0.00	n/a
Senate Bill	609	An Act relative to consumer deductibles	Support	$0.00	n/a
Senate Bill	689	An Act relative to patient access to biomarker testing to provide appropriate therapy	Support	$0.00	n/a
Senate Bill	732	An Act relative to promoting comprehensive transparency in the pharmaceutical industry	Support	$0.00	n/a
House Bill	978	An Act relative to promoting healthcare access and affordability for patients	Support	$0.00	n/a
House Bill	4804	An Act relative to strengthening Massachusetts’ economic leadership	Neutral	$0.00	n/a
House Bill	1176	An Act relative to promoting comprehensive transparency in the pharmaceutical industry	Support	$0.00	n/a
House Bill	5159	An Act enhancing the market review process	Neutral	$0.00	n/a
House Bill	945	An Act to ensure prescription drug cost transparency and affordability	Oppose	$0.00	n/a
House Bill	4891	An Act promoting access and affordability of prescription drugs	Neutral	$0.00	n/a
Senate Bill	612	An Act relative to promoting healthcare access and affordability for patients	Support	$0.00	n/a
			Total amount	$0.00

Meals, Travel, and Entertainment Expenses

No meals, travel, or entertainment expenses were filed for this disclosure reporting period.

Additional Expenses

No additional expenses were filed for this disclosure reporting period.

Campaign Contributions

No campaign contributions were filed for this disclosure reporting period.

Close this page

Connect with Us